Castañón E - Search Results

1

The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.

Castañón E, Soltermann A, López I, Román M, Ecay M, Collantes M, Redrado M, Baraibar I, López-Picazo JM, Rolfo C, Vidal-Vanaclocha F, Raez L, Weder W, Calvo A, Gil-Bazo I. Castañón E, et al. Cancer Lett. 2017 Aug 28;402:43-51. doi: 10.1016/j.canlet.2017.05.012. Epub 2017 May 24. Cancer Lett. 2017. PMID: 28549790

2

Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.

Castañon E, Bosch-Barrera J, López I, Collado V, Moreno M, López-Picazo JM, Arbea L, Lozano MD, Calvo A, Gil-Bazo I. Castañon E, et al. J Transl Med. 2013 Jan 11;11:13. doi: 10.1186/1479-5876-11-13. J Transl Med. 2013. PMID: 23311395 Free PMC article.

3

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.

Ponz-Sarvisé M, Castañón E, Panizo-Santos A, Redrado M, López I, Rosell D, Gil-Aldea I, Calvo A, Nguewa PA, Gil-Bazo I. Ponz-Sarvisé M, et al. Among authors: castanon e. Clin Genitourin Cancer. 2014 Apr;12(2):87-93. doi: 10.1016/j.clgc.2013.08.007. Epub 2013 Oct 12. Clin Genitourin Cancer. 2014. PMID: 24129125

4

Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients.

Ceniceros L, Aristu J, Castañón E, Rolfo C, Legaspi J, Olarte A, Valtueña G, Moreno M, Gil-Bazo I. Ceniceros L, et al. Among authors: castanon e. Clin Transl Oncol. 2016 Mar;18(3):259-68. doi: 10.1007/s12094-015-1361-4. Epub 2015 Aug 5. Clin Transl Oncol. 2016. PMID: 26243396 Review.

5

Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed.

Arévalo E, Castañón E, López I, Salgado J, Collado V, Santisteban M, Rodríguez-Ruiz M, Martín P, Zubiri L, Patiño-García A, Rolfo C, Gil-Bazo I. Arévalo E, et al. Among authors: castanon e. J Transl Med. 2014 Apr 14;12:98. doi: 10.1186/1479-5876-12-98. J Transl Med. 2014. PMID: 24726028 Free PMC article.

6

Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.

Castañón E, Rolfo C, Viñal D, López I, Fusco JP, Santisteban M, Martin P, Zubiri L, Echeveste JI, Gil-Bazo I. Castañón E, et al. J Transl Med. 2015 Aug 7;13:257. doi: 10.1186/s12967-015-0622-x. J Transl Med. 2015. PMID: 26248464 Free PMC article.

7

Take-home message in times of crisis: Is it really better to treat with cisplatin & pemetrexed than cisplatin & gemcitabine in first line NSCLC? The power of statistical considerations.

Rolfo C, Castañon E. Rolfo C, et al. Among authors: castanon e. Lung Cancer. 2015 Dec;90(3):620-2. doi: 10.1016/j.lungcan.2015.09.001. Epub 2015 Sep 7. Lung Cancer. 2015. PMID: 26454774

8

Epidermal Growth Factor Receptor targeting in non-small cell lung cancer: revisiting different strategies against the same target.

Castañón E, Martín P, Rolfo C, Fusco JP, Ceniceros L, Legaspi J, Santisteban M, Gil-Bazo I. Castañón E, et al. Curr Drug Targets. 2014;15(14):1273-83. doi: 10.2174/138945011514141216092935. Curr Drug Targets. 2014. PMID: 25511613 Review.

9

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance.

Van Der Steen N, Pauwels P, Gil-Bazo I, Castañon E, Raez L, Cappuzzo F, Rolfo C. Van Der Steen N, et al. Among authors: castanon e. Cancers (Basel). 2015 Mar 25;7(2):556-73. doi: 10.3390/cancers7020556. Cancers (Basel). 2015. PMID: 25815459 Free PMC article. Review.

10

EGFR mutation testing in nonsmall cell lung cancer patients by using cytology specimens: when the tissue is no longer the issue.

Gil-Bazo I, Castañón E, Fusco JP. Gil-Bazo I, et al. Among authors: castanon e. Cancer Cytopathol. 2011 Oct 25;119(5):354. doi: 10.1002/cncy.20183. Epub 2011 Aug 31. Cancer Cytopathol. 2011. PMID: 21882356 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page